Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease

Abstract

Background Efficient biomarkers for early prediction and diagnosis of an acutely symptomatic carotid plaque rupture event are currently lacking, impairing the ability to diagnose and treat patients with an acute plaque rupture events in a timely fashion. Resolvins are endogenous inflammation-resolving lipid mediators that are induced by inflammatory insults. We hypothesized that resolvin and other lipid profiles in sera likely mark the process towards plaque rupture. Methods Circulating lipids associated with plaque rupture events were quantitatively profiled via targeted mediator-lipidomics using ultraperformance liquid chromatography tandem mass spectrometry in patients with acutely symptomatic and asymptomatic carotid disease. Results Resolvin D1 (RvD1, 82 ± 11 pM vs. 152 ± 17 pM, p = 0.001) and docosahexaenoic acid (DHA) (0.052 ± 0.007 μM versus 0.076 ± 0.008 μM, p = 0.025) levels are decreased in the sera of patients presenting with an acutely symptomatic carotid plaque rupture event (n=21) compared to patients with asymptomatic (n=24) high-grade carotid stenosis. Circulating arachidonic acid (AA) levels, however, were higher (0.429 ± 0.046 μM versus 0.257 ± 0.035 μM, p < 0.01) in acutely symptomatic compared to asymptomatic carotid patients. ROC curve analysis demonstrates that the serum ratio AA:RvD1 (AUC 0.84, sensitivity 0.71, specificity 0.92) and AA:DHA (AUC 0.86, sensitivity 0.90, specificity 0.71) are biomarkers for the risk of atherosclerotic plaque rupture. Conclusions A circulating pro-inflammatory lipid profile, characterized by high AA:RvD1 and AA:DHA, is associated with acutely symptomatic carotid disease and stroke.

Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer’s Disease Cohort

“…Modifications of PUFAs by enzyme oxidation or auto-oxidation can alter the physical properties of neuronal membranes, generate inflammatory mediators, or pro-resolving antiinflammatory mediators (Qu et al, 2015;Bazan et al, 2017;Poreba et al, 2017). Auto-oxidation forms isoprostanes that are indicators of oxidative stress and are neurotoxic.…”

Pro-resolving lipid mediators in vascular disease

“…In early studies, we identified that circulating levels of the SPM 15-epi-lipoxin A 4 (15-epi-LXA 4 ) were significantly lower in individuals with advanced PAD and correlated inversely with disease severity (15). Recent work from other investigators demonstrates that circulating levels of the SPM resolvin D1 (RvD1) or its precursor docosahexaenoic acid (DHA) are reduced in individuals with symptomatic carotid atherosclerosis (33). Thus, an imbalance between proinflammatory and pro-resolving signals may reflect or directly contribute to the progression of atherosclerotic vascular disease in humans (15,20).…”

Resolution of Inflammation is Disturbed in Macrophages of Diabetic Patients with Acute Ischemic Stroke

“…(13) Moreover, it has been reported that ratios of SPMs to leukotriene B4 (LTB 4 ) are reduced in human vulnerable plaques compared to stable ones. (14) These studies implicate a critical role of resolution and SPMs in T2DM and atherosclerosis. In the present study, we set out to study resolution of in ammation in ox-LDL-challenged macrophages derived from peripheral blood mononuclear cells (PBMCs) of DM patients with AIS ex vivo.…”